Key facts
- This page summarizes Stephen Malherbe's Form 4 filing for Enfusion, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Aug 2023, 21:17.
Stephen Malherbe - 28 Jul 2023 Form 4 Insider Report for Enfusion, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 28 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Aug 2023, 21:17:22 UTC
- Prior SEC filing
- 10 Mar 2023
- Next SEC filing
- 28 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Campobasso, as Attorney-in-Fact for Stephen Malherbe
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen Malherbe filed Form 4 for Enfusion, Inc. on 01 Aug 2023.
Change
- Previous filing in this sequence was filed on 10 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENFN
transaction
Class A Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,000,000
- Change %
- Price
- Shares after
- 1,000,000
- Date
- 28 Jul 2023
- Ownership
- See footnote
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ENFN
transaction
Derivative
Common Units of Enfusion Ltd. LLC
Conversion of derivative security
- Transaction value
- $0
- Shares
- -1,000,000
- Change %
- -9.2%
- Price
- $0.000000
- Shares after
- 9,870,386
- Date
- 28 Jul 2023
- Ownership
- See footnote
- Underlying class
- Class A Common Stock
- Underlying amount
- 1,000,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Common Units of Enfusion Ltd. LLC, and the corresponding shares of Class B common stock are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis with the Issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.
Footnote F2
These shares of Class A common stock and Common Units are held by Malherbe Investments LLC. Stephen Malherbe is the sole manager of Malherbe Investments LLC, an estate planning vehicle. The Reporting Person may be deemed to have dispositive power over the Common Units held by Malherbe Investments LLC. Mr. Malherbe disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.